Related Experiment Video
Updated: Aug 2, 2025
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[Current Status and Prospects of Robot-Assisted Surgery in Colorectal Cancer]
Misuzu Yamato1, Yusuke Kinugasa
1Dept. of Gastrointestinal Surgery, Tokyo Medical and Dental University Graduate School of Medicine.
Abstract:
The number of robot-assisted surgeries for rectal cancer has increased in Japan since the insurance coverage of robot-assisted surgery for rectal cancer in 2018. In addition, robot-assisted surgery for colon cancer has not been covered by insurance so far due to a lack of evidence showing its usefulness, but in April 2022, robot-assisted surgery for colon cancer was also be covered by insurance. At the same time, the surgeon requirements for the introduction of robotic surgery have been simplified, so the number of robotic surgeries will increase. Robotic-assisted surgery offers clear three-dimensional high definition images, motion scaling and anti-shake function, and stable forceps manipulation. This compensates for the disadvantages of laparoscopic surgery. Currently, the evidence for robot-assisted colectomy has not been established, but cohort and database studies have reported that robot-assisted colectomy has advantages in terms of open conversion rate, blood loss, and low complication rate. In this article, we summarize the evidence to date for robot-assisted surgery for colon cancer and discuss its future prospects.
Insights
Robot-assisted surgery for colon cancer is now covered by insurance in Japan, following its use in rectal cancer. This advancement offers improved visualization and precision, potentially leading to better patient outcomes.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Medical Technology
Context:
- Robot-assisted surgery for rectal cancer adoption increased in Japan post-2018 insurance coverage.
- Robot-assisted surgery for colon cancer recently gained insurance coverage (April 2022) and simplified surgeon requirements.
- Laparoscopic surgery limitations are addressed by robotic systems offering enhanced visualization and instrument control.
Purpose:
- To review current evidence for robot-assisted colectomy.
- To discuss the future potential of robotic surgery in colon cancer treatment.
- To highlight the advantages of robotic systems in minimally invasive procedures.
Summary:
- Robot-assisted colectomy offers improved 3D HD visualization, motion scaling, and stable instrument handling.
- While robust evidence is emerging, preliminary studies indicate lower open conversion rates, reduced blood loss, and fewer complications.
- Insurance coverage expansion and simplified requirements are expected to drive increased utilization of robotic surgery for colon cancer.
Impact:
- Facilitates wider adoption of advanced robotic surgical techniques for colon cancer.
- Provides a foundation for future research and evidence generation in robot-assisted colectomy.
- Potentially improves patient outcomes and reduces healthcare costs through minimally invasive approaches.
